Regulation of RIG-I-mediated anti-viral innate immunity by post-translational modifications
Regulation of RIG-I-mediated anti-viral innate immunity by post-translational modifications
批准号:
180789143
负责人:
Dr. Effi Susanne Wies, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2011-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Type I Interferons, namely Interferon alpha and Interferon beta, confer an anti-viral state to cells and limit virus replication and dissemination. To elicit an Interferon response mammalian hosts have evolved a variety of pattern recognition receptors, which sense components of invading pathogens and trigger downstream signaling cascades that lead to the transcriptional activation of Interferon alpha/beta. Among these are the Toll-like receptors and the recently identified cytosolic helicases RIG-I and MDA5. Unlike TLRs, RIG-I and MDA5 are ubiquitously expressed and play essential roles in the recognition of RNA viruses in various cell types. Tight regulation of immune signaling pathways is essential for a successful immune response against viral infections. RIG-I anti-viral activity is regulated by post-translational modifications. Lysine 63-linked ubiquitination of RIG-I by the E3 ubiquitin ligase TRIM25 is essential for the interaction of RIG-I with MAVS, a downstream signaling molecule of the pathway, and thereby for Interferon production. Moreover, further data suggest that phosphorylation of RIG-I might as well be important for RIG-I regulation. The proposed study is directed toward investigating the interplay between phosphorylation and ubiquitination to tightly regulate the RIG-I anti-viral interferon response. The main focus will lie on the characterization of the kinase(s) and phosphatase(s) involved in these processes. This study thus promises to identify novel key players of the cellular interferon response against viral infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
RIG-I介导糖酵解在结直肠癌5-氟尿嘧啶耐药中的作用及相关机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘央央
-
依托单位:
牛病毒性腹泻病毒诱导自噬抑制RIG-I-MAVS介导的I型干扰素产生的分子机制研究
-
批准号:QN25C180005
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王静
-
依托单位:
瑞马唑仑在RIG-Ⅰ/NF-κB信号通路介导术后菌群失调诱发围术期认知障碍中的作用研究
-
批准号:2025JJ70336
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曾蕾
-
依托单位:
TOMM20通过促进RIG-I/MAVS和ATP合酶的线粒体定位抑制铁死亡在糖尿病角膜病变中的机制研究
-
批准号:2025JJ90258
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄王乐
-
依托单位:
板蓝根来源细胞外囊泡样颗粒RIEVLP阻断RIG- I/NF-κB/IFN-β信号轴治疗严重流感肺炎的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:梁晓丽
-
依托单位:
乳酸化修饰TRIM25调控RIG-1介导NK细胞免疫抑制在吸烟促进肺
癌恶性进展中作用及分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:成诚
-
依托单位:
葛根汤通过抑制NS1对RIG-I/IFN途径的干扰作用发挥抗流感病毒药效活性
-
批准号:2024QN028
-
项目类别:省市级项目
-
资助金额:4.0万元
-
批准年份:2024
-
负责人:李雅群
-
依托单位:
狂犬病病毒不同毒株感染激活RIG-I信号通路的差异性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:罗永文
-
依托单位:
青鱼STAT1/2负调控RIG-I/IFN信号通路的分子机制
-
批准号:32303050
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘吉
-
依托单位:
RIG-I/MAVS非干扰素依赖通路诱导细胞凋亡介导七鳃鳗抗病毒的机制研究
-
批准号:32360150
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:宋涛
-
依托单位: